Genetic modifiers of non-alcoholic fatty liver disease progression
about
Dietary supplements and pediatric non-alcoholic fatty liver disease: Present and the futureComposite prognostic models across the non-alcoholic fatty liver disease spectrum: Clinical application in developing countriesMutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in miceShugan Xiaozhi Decoction Attenuates Nonalcoholic Steatohepatitis by Enhancing PPARα and L-FABP Expressions in High-Fat-Fed RatsStructural and functional interaction of fatty acids with human liver fatty acid-binding protein (L-FABP) T94A variantFatty Acid Binding Protein-1 (FABP1) and the Human FABP1 T94A Variant: Roles in the Endocannabinoid System and Dyslipidemias.NAFLD Susceptibility Genes and their Association with Type 2 Diabetes and Obesity in a New Mexico Population.Nutrigenomics of high fat diet induced obesity in mice suggests relationships between susceptibility to fatty liver disease and the proteasome.Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.The genetic architecture of NAFLD among inbred strains of miceLoss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female miceMolecular Interactions between NAFLD and Xenobiotic Metabolism.Iron and steatohepatitis.Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD.Genetic and hormonal control of hepatic steatosis in female and male mice.Fuzheng Huayu recipe prevents nutritional fibrosing steatohepatitis in mice.M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease.Hibiscus sabdariffa L. aqueous extract attenuates hepatic steatosis through down-regulation of PPAR-γ and SREBP-1c in diet-induced obese mice.Nonalcoholic Fatty Liver Disease Is a Susceptibility Factor for Perchloroethylene-Induced Liver Effects in Mice.TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD.PREP1 deficiency downregulates hepatic lipogenesis and attenuates steatohepatitis in mice.Liver repercussions of defective gut surveillanceInteraction of volatile organic compounds and underlying liver disease: a new paradigm for risk
P2860
Q26777658-D73D0945-FF9B-4B81-AF9E-DD1B595B068AQ26828855-0C0158A1-8CB4-4D06-8475-708E9A368BEBQ28534250-02529391-9C8C-4E02-8C6E-60FA6C1548DAQ28817618-557727C9-4287-4924-9C48-ED8A77B92295Q33581953-AD004C22-0F8C-4B71-817C-6D59D5784895Q33613330-07EF0717-C4A6-4FBA-818E-8368805F7073Q33768820-E02D8539-F255-405D-8511-E4205860FE6BQ35064319-8F0B2354-FA1E-4307-9A14-73A234DC5502Q35102604-1BA70641-8975-4482-A5B9-0683BE991675Q35825098-7FAD6068-F68E-4614-94E8-D3EB6A610393Q35911451-520BBFD0-9A86-456A-BC92-B0FF50446ECAQ36549795-B689D174-B097-4750-8E4E-02C83AAEF1DDQ37982805-3B073027-C2F4-4D32-9FB2-E486B0AEB3ADQ38128548-2565E432-5520-4A53-99B6-4845E9C6901FQ38204970-2E5CCE9C-E5FE-4D65-8CA7-102431D75966Q38752448-69D51DFA-A16B-4D86-B749-019E5FC3B738Q38798845-AF2C1D24-4007-48AE-8E77-C0555697AD50Q41775019-79B24B79-D72E-4F44-B000-30ACB95E374CQ42710363-F1E79519-A0FA-4928-9B3B-37EC98B69B12Q43529289-DAFFB6CA-6837-4789-B9B7-1248AA27161BQ47951000-E960371B-2E90-41A4-8933-AA536E45C19BQ51271856-C5AD30F3-3E0A-4C0C-B4DD-1F29DEADDB65Q54408005-CB246C52-8678-41B1-ADE8-9F5D37233B95Q56951980-631E2CEF-B179-4931-83B7-EA88E68AB86CQ57784666-920E1010-324E-4186-BB84-3B2D6B53BB49
P2860
Genetic modifiers of non-alcoholic fatty liver disease progression
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Genetic modifiers of non-alcoholic fatty liver disease progression
@ast
Genetic modifiers of non-alcoholic fatty liver disease progression
@en
Genetic modifiers of non-alcoholic fatty liver disease progression
@nl
type
label
Genetic modifiers of non-alcoholic fatty liver disease progression
@ast
Genetic modifiers of non-alcoholic fatty liver disease progression
@en
Genetic modifiers of non-alcoholic fatty liver disease progression
@nl
prefLabel
Genetic modifiers of non-alcoholic fatty liver disease progression
@ast
Genetic modifiers of non-alcoholic fatty liver disease progression
@en
Genetic modifiers of non-alcoholic fatty liver disease progression
@nl
P1476
Genetic modifiers of non-alcoholic fatty liver disease progression
@en
P2093
Christopher P Day
P304
P356
10.1016/J.BBADIS.2011.07.017
P407
P577
2011-08-05T00:00:00Z